2017 - Fellow, National Academy of Inventors
Jack A. Elias mainly investigates Immunology, Inflammation, Fibrosis, Interleukin 13 and Lung. Jack A. Elias regularly ties together related areas like Pulmonary fibrosis in his Immunology studies. His studies deal with areas such as Signal transduction, Cell biology, Matrix metalloproteinase, Macrophage and Programmed cell death as well as Inflammation.
His Fibrosis research focuses on Cancer research and how it relates to Transforming growth factor, Transforming growth factor beta and Receptor. Jack A. Elias has researched Interleukin 13 in several fields, including Vascular endothelial growth factor A, Molecular biology and Effector. His Lung research is multidisciplinary, incorporating perspectives in Endocrinology and Pathology.
Immunology, Inflammation, Cancer research, Lung and Interleukin 13 are his primary areas of study. In his research on the topic of Immunology, Macrophage is strongly related with Fibrosis. In his study, which falls under the umbrella issue of Inflammation, Hyperoxia and Lung injury is strongly linked to Programmed cell death.
His Cancer research research is multidisciplinary, incorporating elements of Transforming growth factor and Metastasis. His research investigates the link between Lung and topics such as Pathology that cross with problems in Respiratory disease. As part of the same scientific family, Jack A. Elias usually focuses on Cytokine, concentrating on Fibroblast and intersecting with Endocrinology, Internal medicine and Molecular biology.
His primary scientific interests are in Immunology, CHI3L1, Cancer research, Lung and Inflammation. His Immunology study incorporates themes from Fibrosis, COPD and Chitinase. His CHI3L1 research includes themes of Receptor, Cytotoxic T cell, Antibody and T cell.
His research in Receptor tackles topics such as Interleukin 13 which are related to areas like Asthma. The study incorporates disciplines such as Retinoic acid receptor beta, Plexin, Immunity and Pathology in addition to Lung. Jack A. Elias has researched Inflammation in several fields, including M2 Macrophage and Ovalbumin.
His main research concerns Immunology, Inflammation, CHI3L1, Lung and Fibrosis. He has included themes like COPD, Downregulation and upregulation and Chitinase in his Immunology study. His Inflammation study combines topics from a wide range of disciplines, such as T cell, Innate immune system, Endocrinology and White adipose tissue.
His CHI3L1 study combines topics in areas such as Receptor and Myofibroblast. Jack A. Elias interconnects Cancer research and Pathology in the investigation of issues within Lung. His studies in Pulmonary fibrosis integrate themes in fields like In vivo and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
Zhou Zhu;Robert J. Homer;Robert J. Homer;Zhonde Wang;Qingsheng Chen.
Journal of Clinical Investigation (1999)
Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions
Sally E. Wenzel;John V. Fahy;Charles Irvin;Stephen P. Peters.
American Journal of Respiratory and Critical Care Medicine (2000)
Asthma: Mechanisms of Disease Persistence and Progression
Lauren Cohn;Jack A. Elias;Geoffrey L. Chupp.
Annual Review of Immunology (2004)
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.
Sophie Molet;Qutayba Hamid;Francis Davoineb;Esra Nutku.
The Journal of Allergy and Clinical Immunology (2001)
Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma
Douglas A. Kuperman;Xiaozhu Huang;Laura L. Koth;Grace H. Chang.
Nature Medicine (2002)
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
Chun Geun Lee;Robert J. Homer;Zhou Zhu;Sophie Lanone.
Journal of Experimental Medicine (2001)
Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation
Zhou Zhu;Tao Zheng;Robert J. Homer;Yoon Keun Kim.
Science (2004)
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase– and cathepsin-dependent emphysema
Tao Zheng;Zhou Zhu;Zhongde Wang;Robert J. Homer;Robert J. Homer.
Journal of Clinical Investigation (2000)
Airway remodeling in asthma.
Jack A. Elias;Zhou Zhu;Geoffrey Chupp;Robert J. Homer.
Journal of Clinical Investigation (1999)
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung.
Chun Geun Lee;Holger Link;Peter Baluk;Robert J Homer.
Nature Medicine (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brown University
Yale University
Yale University
University of Tübingen
Yale University
Duke University
Cornell University
Johns Hopkins University
Yale University
Takeda (United States)
MIT
University of Manchester
University of Basel
University of North Carolina at Chapel Hill
Zhengzhou University
Imperial College London
Royal Agricultural University
Columbia University
Technical University of Munich
University of Miami
Brigham and Women's Hospital
New York University
École Normale Supérieure
University of California, Berkeley
University of Rome Tor Vergata